Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-Label, Single-Arm Study to Assess Growth and Bone Mineral Density in Children ≥6 to <12 Years of Age With Severe Atopic Dermatitis Treated With Dupilumab

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07187089
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:54.956245+00:00
Published At
2025-11-28T00:00:00+00:00
Record Updated At
2025-11-28
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Severe Atopic Dermatitis (AD)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-11-28"
protocolSection.identificationModule.nctId
"NCT07187089"
protocolSection.identificationModule.officialTitle
"An Open-Label, Single-Arm Study to Assess Growth and Bone Mineral Density in Children \u22656 to \u003c12 Years of Age With Severe Atopic Dermatitis Treated With Dupilumab"
protocolSection.statusModule.overallStatus
"WITHDRAWN"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Severe Atopic Dermatitis (AD) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.